Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review.

Muley P, Shah M, Muley A.

Curr Drug Saf. 2013 Jul;8(3):186-94. Review.

PMID:
23859431
[PubMed - indexed for MEDLINE]
2.

[Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].

Bartkowiak-Emeryk M, Breborowicz A, Emeryk A, Kulus M, Kurzawa R, Lis G, Mazurek H, Niedziela M.

Pol Merkur Lekarski. 2004;17 Suppl 2:11-8. Review. Polish.

PMID:
15688664
[PubMed - indexed for MEDLINE]
3.

Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.

Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW.

J Allergy Clin Immunol. 1998 Jul;102(1):32-8.

PMID:
9679845
[PubMed - indexed for MEDLINE]
4.

Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial.

Kemp JP, Osur S, Shrewsbury SB, Herje NE, Duke SP, Harding SM, Faulkner K, Crim CC.

Mayo Clin Proc. 2004 Apr;79(4):458-66.

PMID:
15065610
[PubMed - indexed for MEDLINE]
5.

Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.

Li JT, Ford LB, Chervinsky P, Weisberg SC, Kellerman DJ, Faulkner KG, Herje NE, Hamedani A, Harding SM, Shah T.

J Allergy Clin Immunol. 1999 Jun;103(6):1062-8.

PMID:
10359887
[PubMed - indexed for MEDLINE]
6.

Safety of the newer inhaled corticosteroids in childhood asthma.

Randell TL, Donaghue KC, Ambler GR, Cowell CT, Fitzgerald DA, van Asperen PP.

Paediatr Drugs. 2003;5(7):481-504. Review.

PMID:
12837120
[PubMed - indexed for MEDLINE]
7.

Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.

Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.

Ann Allergy Asthma Immunol. 1999 Mar;82(3):273-80.

PMID:
10094218
[PubMed - indexed for MEDLINE]
8.

Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.

Sorkness CA, LaForce C, Storms W, Lincourt WR, Edwards L, Rogenes PR.

Clin Ther. 1999 Feb;21(2):353-67.

PMID:
10211538
[PubMed - indexed for MEDLINE]
9.

Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.

Casale TB, Nelson HS, Stricker WE, Raff H, Newman KB.

Ann Allergy Asthma Immunol. 2001 Nov;87(5):379-85.

PMID:
11730179
[PubMed - indexed for MEDLINE]
10.

Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.

Wasserman RL, Baker JW, Kim KT, Blake KV, Scott CA, Wu W, Faris MA, Crim C.

Ann Allergy Asthma Immunol. 2006 Jun;96(6):808-18.

PMID:
16802768
[PubMed - indexed for MEDLINE]
11.

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.

Lipworth BJ.

Arch Intern Med. 1999 May 10;159(9):941-55.

PMID:
10326936
[PubMed - indexed for MEDLINE]
12.

Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.

Kramer S, Rottier BL, Scholten RJ, Boluyt N.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD010352. doi: 10.1002/14651858.CD010352. Review.

PMID:
23450613
[PubMed - indexed for MEDLINE]
13.

Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.

Lee DK, Bates CE, Currie GP, Cowan LM, McFarlane LC, Lipworth BJ.

Ann Allergy Asthma Immunol. 2004 Sep;93(3):253-8.

PMID:
15478385
[PubMed - indexed for MEDLINE]
14.

Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.

Lipworth BJ, Kaliner MA, LaForce CF, Baker JW, Kaiser HB, Amin D, Kundu S, Williams JE, Engelstaetter R, Banerji DD.

Ann Allergy Asthma Immunol. 2005 Apr;94(4):465-72.

PMID:
15875528
[PubMed - indexed for MEDLINE]
15.
16.

Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma.

Roux C, Kolta S, Desfougères JL, Minini P, Bidat E.

Pediatrics. 2003 Jun;111(6 Pt 1):e706-13.

PMID:
12777589
[PubMed - indexed for MEDLINE]
17.
18.

Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group.

Allen DB, Bronsky EA, LaForce CF, Nathan RA, Tinkelman DG, Vandewalker ML, Konig P.

J Pediatr. 1998 Mar;132(3 Pt 1):472-7.

PMID:
9544904
[PubMed - indexed for MEDLINE]
19.

A longitudinal assessment of the effect of inhaled fluticasone propionate therapy on adrenal function and growth in young children with asthma.

Iles R, Williams RM, Deeb A, Ross-Russell R, Acerini CL.

Pediatr Pulmonol. 2008 Apr;43(4):354-9. doi: 10.1002/ppul.20770. Erratum in: Pediatr Pulmonol. 2008 Jul;43(7):727-8. Williams, R W [corrected to Williams, R M].

PMID:
18286548
[PubMed - indexed for MEDLINE]
20.

[Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].

Bartkowiak-Emeryk M, Breborowicz A, Emeryk A, Kulus M, Kurzawa R, Lis G, Mazurek H, Niedziela M.

Pol Merkur Lekarski. 2004;17 Suppl 2:5-10. Review. Polish.

PMID:
15688663
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk